Back to News
Market Impact: 0.25
Zepp Health Corporation - Depositary Receipt Price Target Decreased by 29.06% to $44.74
Source: Nasdaq
Analyst InsightsAnalyst Estimates
Zepp Health’s average one-year analyst price target was revised down 29.06% to $44.74 per share from $63.07, with the prior estimate dated September 29, 2026. The article excerpt provides no additional context or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.30
Ticker Sentiment
ZEPP-0.40
More News
- Oura sues rival Ultrahuman again, threatening its U.S. smart ring comeback
- SpaceX bear flips to big bull because of AI business. Analyst now sees 70% gain
- Williams Trading cuts Deckers Outdoor stock price target on weak DTC trends
- Jefferies raises Zymeworks stock price target on Roche deal
- Truist raises United Rentals stock price target on strong margins
- Century Casinos receives Nasdaq notice for minimum market value deficiency